AGM/EGMApr 27, 2026, 04:35 PM
ABEO Sets Annual Meeting for June 12, 2026; Proposes 5 Items
AI Summary
Abeona Therapeutics Inc. announced its Annual Meeting of Stockholders will be held virtually on June 12, 2026. Stockholders will vote on five proposals, including the election of three Class 1 directors, an advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor. Key proposals also include increasing the shares reserved for the 2023 Equity Incentive Plan from 8.4 million to 11.5 million and removing the advance notice provision for director nominations from the Company's Certificate of Incorporation.
Key Highlights
- Annual Meeting of Stockholders scheduled for June 12, 2026, held virtually.
- Proposes electing Michael Amoroso, Keith A. Goldan, and Bernhardt G. Zeiher, M.D. as Class 1 directors.
- Seeks approval to increase shares under 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.
- Proposes advisory approval for named executive officers' compensation.
- Seeks ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2026.
- Proposes amending Certificate of Incorporation to remove advance notice for director nominations.
- Record date for voting is April 15, 2026, with 56,882,523 shares outstanding.
- Nantahala Capital Management, LLC holds 9.1% (5,184,662 shares) of common stock.
Price Impact
More from ABEO